Immuneering (IMRX)
NASDAQ:IMRX
US Market
Holding IMRX?
Track your performance easily

Immuneering (IMRX) Similar Stocks

278 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
I-MAB
$83.19M
-0.71
-25.17%
2 Buy
0 Hold
0 Sell
Moderate Buy
Keros Therapeutics
$2.72B
-13.04
130.44%
13 Buy
0 Hold
0 Sell
Strong Buy
Fulcrum Therapeutics
$217.15M
-9.95
2.95%
0 Buy
5 Hold
1 Sell
Hold
Blueprint Medicines
$6.44B
-47.84
76.12%
8 Buy
5 Hold
0 Sell
Moderate Buy
Immuneering
$57.23M
-1.00
-63.46%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
IMAB
I-MAB
1.10
-0.47
-29.94%
KROS
Keros Therapeutics
67.91
38.34
129.66%
FULC
Fulcrum Therapeutics
3.49
>-0.01
-0.29%
BPMC
Blueprint Medicines
100.83
41.98
71.33%
IMRX
Immuneering
1.90
-3.28
-63.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis